Search
for
Sort by
Research 931–960 of 1000+
- 42736 Safety Assessments in the Multinational Phase 3 THRIVE-AA1 Trial with CTP-543 (Deuruxolitinib) in Adult Patients with Moderate to Severe Alopecia Areata
- Dual improvement of alopecia areata and immune thrombocytopenia with baricitinib: a case report
- Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata
- Oral abrocitinib for treatment of refractory alopecia areata: A retrospective study
- JAK1 gain-of-function variant causes alopecia areata, atopic dermatitis, and autoimmune thyroid disease
- Clinical Outcomes of Ritlecitinib in Treatment-Refractory Alopecia Areata: A Single-Center Real-World Study
- Molecular Predictors of Ritlecitinib Efficacy in Alopecia Areata: Role of JAK3-Dependent Inflammation and Follicular Integrity
- 802 Molecular effect of brepocitinib in hidradenitis suppurativa (HS)
- Tofacitinib Treatment in Patients With Active COVID-19 Infection
- Abrocitinib in the Treatment of Severe Alopecia Areata in a Pediatric Patient: A Case Report
- 0480 Upadacitinib monotherapy for treatment of pyoderma gangrenosum: A case series
- Successful treatment of severe diffuse alopecia areata with abrocitinib
- Baricitinib in the Management of Coexisting Alopecia Areata and Atopic Dermatitis: A Case Report
- Nanostructured lipid carriers promote percutaneous absorption and hair follicle targeting of tofacitinib for treating alopecia areata
- Upadacitinib for the treatment of alopecia areata – A case report
- S3886 Concurrent Management of Crohn's Ileitis and Alopecia Universalis With Upadacitinib
- 290 Brepocitinib improves cicatricial alopecia and downregulates key T-helper biomarkers
- Repigmentation through Melanocyte Regeneration in Vitiligo
- Application of Baricitinib in Dermatology
- Off-Label Uses of Abrocitinib: Review of Emerging Therapeutic Applications beyond Atopic Dermatitis
- Efficacy and Potential Mechanisms of Naringin in Atopic Dermatitis
- Effective treatment of refractory alopecia areata in pediatric patients with oral abrocitinib
- Rapid hair regrowth in an alopecia universalis patient with deucravacitinib: A case report
- Upadacitinib: A New Weapon for the Treatment of Twenty-Nail Dystrophy
- Review of Promising Off-Label Use of Deucravacitinib
- Unique Circulating MicroRNA Signatures Distinguish Severe Alopecia Areata from Other Inflammatory Skin Diseases
- Comprehensive Safety Exposure‐Response Analysis to Support Ritlecitinib Dose Selection
- Dissecting Cellulitis of the Scalp Successfully Treated with a Combination of Ixekizumab and Tofacitinib
- Tofacitinib in alopecia areata and HIV: A curious intersection of immunomodulation, hair regrowth, and hypertrichosis
- Case Report: Baricitinib improved alopecia areata in a pediatric patient with atopic dermatitis